197.01M
Market cap
Current P/E
41.15x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis.

Similar securities

Based on sector and market capitalization

Report issue